Curtis Ruegg, EVP, Technical Operations at Revance Therapeutics, Inc. (RVNC), sold 2,500 shares at $25.00 ($66K) on 2015-05-15, disclosed to the SEC on 2015-05-19.
Scheduled sale ($66k) by EVP, Technical Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.00 | 500 | $13K | 19.0% |
| 2 | $26.68 | 500 | $13K | 20.2% |
| 3 | $26.70 | 500 | $13K | 20.3% |
| 4 | $26.72 | 1,000 | $27K | 40.5% |
| Total | $26.36 avg | 2,500 | $66K | 100% |
| Filing → |
| RVNC | SELL | 2016-04-13 | $19K | — | Filing → |
| RVNC | SELL | 2016-03-09 | $20K | — | Filing → |
| RVNC | SELL | 2016-02-10 | $18K | — | Filing → |